| 臺大學術典藏 |
2020-11-27T08:14:30Z |
Hormonal and body-size factors in relation to breast cancer risk: A prospective study of 11,889 women in a low-incidence area
|
CHANG-YAO HSIEH; You S.-L.; Chen C.-J.; Sun C.-A.; Wu M.-H.; Chou Y.-C.; Yu J.-C.; Yu C.-P.; Wu C.-C.; Chu C.-M.; Yang T.; Lai C.-H. |
| 臺大學術典藏 |
2020-11-27T03:25:02Z |
Timely thrombectomy can improve patency of hemodialysis arteriovenous fistulas
|
KUAN-YU HUNG; Wu C.-C.; Chuang S.-Y.; Hsieh M.-Y.;Lin L.;Chen T.-Y.;Chen D.-M.;Lee M.-H.;Shen Y.-F.;Yang C.-W.;Chuang S.-Y.;Wu C.-C.;Kuan-Yu Hung; Hsieh M.-Y.; Lin L.; Chen T.-Y.; Chen D.-M.; Lee M.-H.; Shen Y.-F.; Yang C.-W. |
| 臺大學術典藏 |
2020-11-19T03:20:01Z |
Using the Acoustic Interference Pattern to Locate the Focus of a High-Intensity Focused Ultrasound (HIFU) Transducer
|
Wu C.-C.; Chen C.-N.; Ho M.-C.; Chen W.-S.; PO-HUANG LEE |
| 臺大學術典藏 |
2020-11-19T03:19:57Z |
Minimizing abdominal wall damage during high-intensity focused ultrasound ablation by inducing artificial ascites
|
Chen C.-N.; Yen J.-Y.; PO-HUANG LEE; Wu C.-C.; Chen W.-S.; Ho M.-C.; Huang K.-W. |
| 臺大學術典藏 |
2020-11-19T03:19:55Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:36Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.;Chen M.-F.;Li L.-A.;Po-Huang Lee;Jeng L.-B.;Lin D.-Y.;Wu C.-C.;Mok K.-T.;Chen C.-L.;Lee W.-C.;Chau G.-Y.;Chen Y.-S.;Lui W.-Y.;Hsiao C.-F.;Whang-Peng J.;Chen P.-J.; Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:23Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.; Liu C.-J.; Chang J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B. |
| 臺大學術典藏 |
2020-11-19T03:19:15Z |
The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network
|
Chen C.-L.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; PO-HUANG LEE; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F.; Chen P.-J.; Huang S.-F.; Chang I.-C. |
| 臺大學術典藏 |
2020-11-12T03:02:43Z |
2012 Guidelines of the Taiwan Society of Cardiology (TSOC) for the diagnosis and treatment of heart failure
|
Cherng W.-J.; Pai H.-Y.; PEY-RONG CHEN; Liu M.-H.; Fu T.-C.; Wang C.-H.; Tsai F.-C.; Huang J.-L.; Ueng K.-C.; Chen P.-S.; Lin W.-S.; Wu C.-C.; Li A.-H.; Yin W.-H.; Cheng J.-J.; Yu W.-C.; Chen J.-H.; Wang C.-C.; Wang C.-C.;Chen J.-H.;Yu W.-C.;Cheng J.-J.;Yin W.-H.;Wu C.-C.;Li A.-H.;Lin W.-S.;Chen P.-S.;Ueng K.-C.;Huang J.-L.;Tsai F.-C.;Wang C.-H.;Fu T.-C.;Liu M.-H.;Pey-Rong Chen;Pai H.-Y.;Cherng W.-J. |
| 臺大學術典藏 |
2020-11-11T08:20:00Z |
Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment
|
Jeng J.-S.; Wu C.-C.; Yang K.-C.; CHIH-HAO CHEN; Yang S.-Y.; Chiu M.-J.; Tang S.-C. |
| 臺大學術典藏 |
2020-11-03T15:39:34Z |
Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas
|
CHENG-PING WANG; Chen T.-C; Chang Y.-L; Ko J.-Y; Yang T.-L; Lo F.-Y; Hu Y.-L; Chen P.-L; Wu C.-C; Lou P.-J. |
| 臺大學術典藏 |
2020-11-03T12:37:36Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Wu C.-C.;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Li-Kai Tsai;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L.; Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; LI-KAI TSAI; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-11-03T12:12:41Z |
Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
|
Chen H.-H.; Wu C.-C.; Liu B.-H.; Chiu M.-J.; Yang S.-Y.; Yang S.-Y.;Chiu M.-J.;Chen T.-F.;Chin-Hsien Lin;Jeng J.-S.;Tang S.-C.;Lee Y.-F.;Yang C.-C.;Liu B.-H.;Chen H.-H.;Wu C.-C.; Yang C.-C.; Lee Y.-F.; Tang S.-C.; Jeng J.-S.; CHIN-HSIEN LIN; Chen T.-F. |
| 臺大學術典藏 |
2020-11-03T11:57:01Z |
Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
|
Yang S.-Y.; Ming-Jang Chiu; Chen T.-F.; Lin C.-H.; Jeng J.-S.; Tang S.-C.; Lee Y.-F.; Yang C.-C.; Liu B.-H.; Chen H.-H.; Wu C.-C.; Yang S.-Y.; MING-JANG CHIU et al. |
| 臺大學術典藏 |
2020-11-03T11:56:56Z |
Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment
|
Tang S.-C.;Yang K.-C.;Chen C.-H.;Yang S.-Y.;Ming-Jang Chiu;Wu C.-C.;Jeng J.-S.; Tang S.-C.; Yang K.-C.; Chen C.-H.; Yang S.-Y.; MING-JANG CHIU; Wu C.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2020-11-03T11:56:55Z |
Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects
|
Lue L.-F.; Pai M.-C.; Chen T.-F.; Hu C.-J.; Huang L.-K.; Lin W.-C.; Wu C.-C.; Jeng J.-S.; Blennow K.; Sabbagh M.N.; Yan S.-H.; Wang P.-N.; Yang S.-Y.; Hatsuta H.; Morimoto S.; Takeda A.; Itoh Y.; Liu J.; Xie H.; MING-JANG CHIU |
| 臺大學術典藏 |
2020-11-03T11:56:54Z |
Corrigendum: Age-Dependent Relationship Between Plasma A?40 and A?42 and Total Tau Levels in Cognitively Normal Subjects (Frontiers in Aging Neuroscience, (2019), 11, 10.3389/fnagi.2019.00222)
|
Lue L.-F.; Pai M.-C.; Chen T.-F.; Hu C.-J.; Huang L.-K.; Lin W.-C.; Wu C.-C.; Jeng J.-S.; Blennow K.; Sabbagh M.N.; Yan S.-H.; Wang P.-N.; Yang S.-Y.; Hatsuta H.; Morimoto S.; Takeda A.; Itoh Y.; Liu J.; Xie H.; MING-JANG CHIU |
| 臺大學術典藏 |
2020-11-03T11:56:54Z |
Blood NfL: A biomarker for disease severity and progression in Parkinson disease
|
Lin C.-H.;Li C.-H.;Yang K.-C.;Lin F.-J.;Wu C.-C.;Chieh J.-J.;Ming-Jang Chiu; Lin C.-H.; Li C.-H.; Yang K.-C.; Lin F.-J.; Wu C.-C.; Chieh J.-J.; MING-JANG CHIU |
| 臺大學術典藏 |
2020-11-03T11:44:46Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Yeh H.-I.; Wu C.-C.; Chen J.-W.; Yu T.-Y.; Lee C.-C.; Liou C.-W.; Tang S.-C.; Chien S.-C.; Liu P.-Y.; Su C.-H.; Chien K.-L.; Lin T.-H.; Charng M.-J.; JIANN-SHING JENG; Ueng K.-C.; Li Y.-H.; Li Y.-H.;Ueng K.-C.;Jiann-Shing Jeng;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Tang S.-C.;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Chao T.-H.; Wang C.-Y. |
| 臺大學術典藏 |
2020-11-03T11:44:37Z |
Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment
|
JIANN-SHING JENG; Wu C.-C.; Chiu M.-J.; Yang S.-Y.; Chen C.-H.; Yang K.-C.; Tang S.-C.; Tang S.-C.;Yang K.-C.;Chen C.-H.;Yang S.-Y.;Chiu M.-J.;Wu C.-C.;Jiann-Shing Jeng |
| 臺大學術典藏 |
2020-11-03T11:20:32Z |
Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
|
Chen H.-H.; Wu C.-C.; Liu B.-H.; Lee Y.-F.; Yang C.-C.; Tang S.-C.; Jeng J.-S.; Yang S.-Y.;Chiu M.-J.;Ta-Fu Chen;Lin C.-H.;Jeng J.-S.;Tang S.-C.;Lee Y.-F.;Yang C.-C.;Liu B.-H.;Chen H.-H.;Wu C.-C.; Yang S.-Y.; Chiu M.-J.; TA-FU CHEN; Lin C.-H. |
| 臺大學術典藏 |
2020-11-03T11:08:19Z |
Thrombolytic therapy is an only determinant factor for stroke evolution in large anterior choroidal artery infarcts
|
Wu M.-C.;Tsai L.-K.;Wu C.-C.;Yeh S.-J.;Sung-Chun Tang;Chen Y.-J.;Chen C.-L.;Jeng J.-S.; Wu M.-C.; Tsai L.-K.; Wu C.-C.; Yeh S.-J.; SUNG-CHUN TANG; Chen Y.-J.; Chen C.-L.; Jeng J.-S. |
| 臺大學術典藏 |
2020-11-03T11:08:10Z |
2017 Taiwan lipid guidelines for high risk patients
|
Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; SUNG-CHUN TANG; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Chien K.-L.; Wang C.-Y.; Charng M.-J.; Lin T.-H.; Jeng J.-S.; Li Y.-H.; Ueng K.-C.; Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Sung-Chun Tang;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients |
| 臺大學術典藏 |
2020-11-03T11:08:05Z |
Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with Dementia
|
Sung-Chun Tang;Yang K.-C.;Hu C.-J.;Chiou H.-Y.;Wu C.C.;Jeng J.-S.; SUNG-CHUN TANG; Yang K.-C.; Hu C.-J.; Chiou H.-Y.; Wu C.C.; Jeng J.-S. |
| 臺大學術典藏 |
2020-11-03T11:08:02Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Liu P.-Y.; Chao T.-H.; Wang C.-Y.; Chien K.-L.; Lin T.-H.; Charng M.-J.; Jeng J.-S.; Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Sung-Chun Tang;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; Yeh H.-I.; Wu C.-C.; Yu T.-Y.; Chen J.-W.; SUNG-CHUN TANG; Lee C.-C.; Liou C.-W.; Chien S.-C.; Su C.-H. |
| 臺大學術典藏 |
2020-11-03T11:08:00Z |
Plasma β-Amyloids and Tau Proteins in Patients with Vascular Cognitive Impairment
|
Sung-Chun Tang;Yang K.-C.;Chen C.-H.;Yang S.-Y.;Chiu M.-J.;Wu C.-C.;Jeng J.-S.; SUNG-CHUN TANG; Yang K.-C.; Chen C.-H.; Yang S.-Y.; Chiu M.-J.; Wu C.-C.; Jeng J.-S. |
| 臺大學術典藏 |
2020-11-03T11:07:53Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; SUNG-CHUN TANG; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L.; Wang C.-Y.; Huang W.-C.; Chang W.-T.; Chen Z.-C.; Huang C.-W.; Chen P.-W.; Wu C.-K.; Huang C.-C.; Chang K.-C.; Wu C.-C.; Yeh H.-I.; Wang Y.-C.; Lin T.-H.; Chen J.-W.; Li Y.-H.; Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Wu C.-C.;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Sung-Chun Tang;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L. |
| 臺大學術典藏 |
2020-11-03T07:37:15Z |
Contribution of adiponectin and its type 1 receptor to age-related hearing impairment
|
Wu C.-C.; Tsai C.-H.; Lu Y.-C.; Lin H.-C.; Hwang J.-H.; Lin Y.-H.; Yang W.-S.; Chen P.-J.; WEI-CHIH LIAO; Lee Y.L.; Liu T.-C.; Hsu C.-J. |
| 臺大學術典藏 |
2020-11-02T02:05:09Z |
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival
|
Wu C.-Y.; MING-SHIANG WU; Chiang E.-P.; Wu C.-C.; Chen Y.-J.; Chen C.-J.; Chi N.-H.; Chen G.-H.; Lin J.-T. |
| 臺大學術典藏 |
2020-10-27T12:04:32Z |
Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas
|
Lo F.-Y; Ko J.-Y; Yang T.-L; Chang Y.-L; Chen T.-C; Wang C.-P; Wang C.-P;Chen T.-C;Chang Y.-L;Ko J.-Y;Yang T.-L;Lo F.-Y;Hu Y.-L;Chen P.-L;Wu C.-C;Pei-Jen Lou; Hu Y.-L; Chen P.-L; Wu C.-C; PEI-JEN LOU |
| 臺大學術典藏 |
2020-10-26T01:48:49Z |
Prediction Model for Audiological Outcomes in Patients with GJB2 Mutations
|
Chen P.-Y.; Lin Y.-H.; Liu T.-C.; Lin Y.-H.; Tseng L.-H.; Yang T.-H.; PEI-LUNG CHEN; Wu C.-C.; Hsu C.-J. |
| 臺大學術典藏 |
2020-10-26T01:48:46Z |
An integrative approach for pediatric auditory neuropathy spectrum disorders: revisiting etiologies and exploring the prognostic utility of auditory steady-state response
|
Lin P.-H.;Hsu C.-J.;Lin Y.-H.;Lin Y.-H.;Yang S.-Y.;Yang T.-H.;Pei-Lung Chen;Wu C.-C.;Liu T.-C.; Lin P.-H.; Hsu C.-J.; Lin Y.-H.; Lin Y.-H.; Yang S.-Y.; Yang T.-H.; PEI-LUNG CHEN; Wu C.-C.; Liu T.-C. |
| 臺大學術典藏 |
2020-10-23T03:49:07Z |
Concurrent Hearing, Genetic, and Cytomegalovirus Screening in Newborns, Taiwan
|
Lu C.-Y.; PO-NIEN TSAO; Ke Y.-Y.; Lin Y.-H.; Lin Y.-H.; Hung C.-C.; Su Y.-N.; Hsu W.-C.; Hsieh W.-S.; Huang L.-M.; Wu C.-C.; Hsu C.-J. |
| 臺大學術典藏 |
2020-10-23T03:49:03Z |
Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFβ signaling through TGFBR1 stabilization
|
Sperling A.I.; Guzy R.D.; Fang Y.; Yang K.-C.; Lin S.-L.; Wu Y.-F.; Lin S.-J.; Lu F.-L.; PO-NIEN TSAO; Lin T.-H.; Lo S.-C.; Tseng Y.-S.; Wu W.-L.; Chen C.-N.; Wu C.-C.; Lee T.-H.; Yeh C.-F.; Lee Y.-T.; Shih Y.-C.; Chen Y.-T.; Hung C.-T.; You M.-Y.; Wu P.-C.; Shentu T.-P.; Huang R.-T.; Lin Y.-S. |
| 臺大學術典藏 |
2020-09-30T08:49:56Z |
First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla
|
Su M.-Y.M.; Yang K.-C.; Wu C.-C.; YEN-WEN WU; Yu H.-Y.; Tseng R.-Y.; Tseng W.-Y.I. |
| 臺大學術典藏 |
2020-09-30T08:49:40Z |
Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease
|
Yang W.-S.; Huang C.-L.; YEN-WEN WU; Wu C.-C.; Lin L.; Wu Y.-C.; Hsu P.-Y.; Jong Y.-S. |
| 臺大學術典藏 |
2020-09-30T08:49:40Z |
Usefulness of magnetocardiography to detect coronary artery disease and cardiac allograft vasculopathy
|
YEN-WEN WU; Lee C.-M.; Liu Y.-B.; Wang S.-S.; Huang H.-C.; Tseng W.-K.; Jui H.-Y.; Wang S.-Y.; Horng H.-E.; Yang H.-C.; Wu C.-C. |
| 臺大學術典藏 |
2020-09-30T08:49:39Z |
QTcheterogeneity in rest magnetocardiography is sensitive to detect coronary artery disease: In comparison with stress myocardial perfusion imaging
|
YEN-WEN WU; Lin L.-C.; Tseng W.-K.; Liu Y.-B.; Kao H.-L.; Lin M.-S.; Huang H.-C.; Wang S.-Y.; Horng H.-E.; Yang H.-C.; Wu C.-C. |
| 臺大學術典藏 |
2020-09-30T08:49:37Z |
Impact on pulmonary arterial pressures after repeated endovascular thrombectomy of dialysis grafts: A prospective follow-up study
|
Hsieh M.-Y.; Lai C.-L.; YEN-WEN WU; Lin L.; Ho M.-C.; Wu C.-C. |
| 臺大學術典藏 |
2020-09-30T08:49:34Z |
Serum angiopoietin-like protein 2 concentrations are independently associated with heart failure
|
YEN-WEN WU; Wu C.-C.; Hwang J.-J.; Yang W.-S.; Huang C.-L. |
| 臺大學術典藏 |
2020-09-30T08:49:31Z |
TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management
|
YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Wang C.-C.; Chang H.-Y.; Yin W.-H. |
| 臺大學術典藏 |
2020-09-30T08:49:30Z |
The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients
|
Lin G.-M.; Li Y.-H.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I. |
| 臺大學術典藏 |
2020-09-30T08:49:28Z |
One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry
|
Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Yin W.-H.; Huang J.-L.; Lin W.-S.; Voon W.-C.; Hsu C.-H.; Wen M.-S.; Wu C.-C.; Chu P.-H.; YEN-WEN WU; Wang C.-C.; Chang H.-Y. |
| 臺大學術典藏 |
2020-09-30T08:49:28Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:27Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:26Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; YEN-WEN WU; Wu C.-C.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-09-30T08:49:25Z |
In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry
|
Chen K.-C.; Yin W.-H.; Wu C.-C.; Chan S.-H.; YEN-WEN WU; Wang K.Y.; Chang K.-C.; Hwang J.-J.; Voon W.-C.; Hsieh I.-C.; Chong J.-T.; Lin W.-S.; Hsu C.-N.; Ueng K.-C.; Hsia C.-P.; Liu J.-C.; Yeh J.-S.; Mar G.-Y.; Shih J.-Y.; Kuo J.-Y.; Tsao H.-M.; Tseng W.-K.; Yang C.-H.; Chang C.-C.; Chiang C.-E.; Lei M.-H.; Lin J.-F.; Shyu K.-G. |
| 臺大學術典藏 |
2020-09-30T08:49:23Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Tseng W.-K.; YEN-WEN WU; Ho S.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:23Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Tseng W.-K.; Yin W.-H.; YEN-WEN WU; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators; Ho L.-T.; Lin F.-J. |
